Certified by Founder Lodge
Antiva Biosciences, Inc.
United States - South San Francisco, California
START UP
1 Disclosed Funding Rounds $53,000,000
0 Participating Investments
-
Founded date
2012
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. We aim to stop cancer befo
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 27 ,2023 | Series E | $53,000,000 |
GV (Google Ventures)
Canaan
Sofinnova Investments
BioImpact Capital, an Affiliate of MPM Capital
Lumira Ventures
Adjuvant Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
OTPLESS | $3,500,000 | (May 17, 2024)
Watershed Health | $13,600,000 | (May 17, 2024)
Aeropay | $20,000,000 | (May 17, 2024)
c/side | $1,700,000 | (May 17, 2024)
SINE Digital | $2,500,000 | (May 17, 2024)
